Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Travoprost vs Latanoprost Ocular Surface Effects
NCT01315574Phase 4Terminated
- Sponsor
- Massachusetts Eye and Ear
- Start
- Feb 2011
- Primary completion
- Dec 2013
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of travoprost in Glaucoma, sponsored by Massachusetts Eye and Ear. Started Feb 2011; status: terminated.
02
Drugs
travoprost
03
Conditions
Glaucoma
Beyond the preview
Go deeper on NCT01315574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01315574.